InvestorsHub Logo
Followers 361
Posts 31782
Boards Moderated 0
Alias Born 08/16/2010

Re: i_like_bb_stock post# 11255

Friday, 06/08/2018 9:27:42 AM

Friday, June 08, 2018 9:27:42 AM

Post# of 12003
VacceX is committed to developing novel immunotherapeutics for the benefit of cancer patients. The company’s scientific foundation is based on drug delivery platforms for immune modulating drugs. We are a science driven company seeking to understand the immune system suppression in cancer and the complexity of reprogramming the immune system in the tumor microenvironment by use of advanced drug delivery technology.



The VacceX technology platform aims to improve cancer therapy by local delivery of Toll Like Receptor (TLR) agonists in combination with radiotherapy. The treatment outcome will be improved local tumor control, anti-metastatic treatment, and a memory effect that reduces the risk of relapse (cancer vaccination).

NOVEL IMMUNOTHERAPEUTICS FOR TREATMENT OF CANCER


http://www.vaccex.com/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.